APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antivenom

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

Selected research

Industry Growth & Trends

Global Antivenom Industry Growth and Trends Forecast to 2032

26 December 2025102 pages

Choose your research edition.

Industry ResearchAntivenom Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Antivenom Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Antivenom Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antivenom Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Antivenom Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Antivenom market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antivenom market size, estimates, and forecasts are presented in terms of sales volume (K Vials) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antivenom market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antivenom.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antivenom market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antivenom Market by Company

CSL

Merck

BTG

Pfizer

Haffkine Bio-Pharmaceutical

Rare Disease Therapeutics

Flynn Pharma

Vins Bioproducts

Bharat Serums and Vaccines

Serum Biotech

MicroPharm

Antivenom Segment by Type

Polyvalent antivenom

Monovalent antivenom

Antivenom Segment by Application

Non-profit Institutions

Hospitals and Clinic

Antivenom Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antivenom market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antivenom and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antivenom.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antivenom manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antivenom in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Polyvalent antivenom Table 2. Major Company of Monovalent antivenom Table 3. Global Antivenom Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Antivenom Sales by Type (2021-2026) & (K Vials) Table 5. Global Antivenom Sales Market Share in Volume by Type (2021-2026) Table 6. Global Antivenom Sales by Type (2021-2026) & (US$ Million) Table 7. Global Antivenom Sales Market Share in Value by Type (2021-2026) Table 8. Global Antivenom Price by Type (2021-2026) & (USD/Vial) Table 9. Global Antivenom Sales by Type (2027-2032) & (K Vials) Table 10. Global Antivenom Sales Market Share in Volume by Type (2027-2032) Table 11. Global Antivenom Sales by Type (2027-2032) & (US$ Million) Table 12. Global Antivenom Sales Market Share in Value by Type (2027-2032) Table 13. Global Antivenom Price by Type (2027-2032) & (USD/Vial) Table 14. North America Antivenom Sales by Type (2021-2026) & (K Vials) Table 15. North America Antivenom Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Antivenom Sales by Type (2021-2026) & (K Vials) Table 17. Europe Antivenom Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Antivenom Sales by Type (2021-2026) & (K Vials) Table 19. Asia-Pacific Antivenom Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Antivenom Sales by Type (2021-2026) & (K Vials) Table 21. Latin America Antivenom Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Antivenom Sales by Type (2021-2026) & (K Vials) Table 23. Middle East and Africa Antivenom Sales by Type (2021-2026) & (US$ Million) Table 24. Antivenom Industry Trends Table 25. Antivenom Industry Drivers Table 26. Antivenom Industry Opportunities and Challenges Table 27. Antivenom Industry Restraints Table 28. Global Antivenom Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Antivenom Revenue Market Share by Company (2021-2026) Table 30. Global Antivenom Sales by Company (2021-2026) & (K Vials) Table 31. Global Antivenom Sales Share by Company (2021-2026) Table 32. Global Antivenom Market Price by Company (2021-2026) & (USD/Vial) Table 33. Global Antivenom Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Antivenom Major Company Production Sites and Headquarters Table 35. Global Antivenom Company, Product Type & Application Table 36. Global Antivenom Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Antivenom by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Antivenom Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Antivenom Sales by Region (2021-2026) & (K Vials) Table 41. Global Antivenom Sales Market Share in Volume by Region (2021-2026) Table 42. Global Antivenom Sales by Region (2021-2026) & (US$ Million) Table 43. Global Antivenom Sales Market Share in Value by Region (2021-2026) Table 44. Global Antivenom Sales (K Vials), Value (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 45. Global Antivenom Sales by Region (2027-2032) & (K Vials) Table 46. Global Antivenom Sales Market Share in Volume by Region (2027-2032) Table 47. Global Antivenom Sales by Region (2027-2032) & (US$ Million) Table 48. Global Antivenom Sales Market Share in Value by Region (2027-2032) Table 49. Global Antivenom Sales (K Vials), Value (US$ Million), Price (USD/Vial) and Gross Margin (2027-2032) Table 50. Global Antivenom Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Antivenom Sales by Application (2021-2026) & (K Vials) Table 52. Global Antivenom Sales Market Share in Volume by Application (2021-2026) Table 53. Global Antivenom Sales by Application (2021-2026) & (US$ Million) Table 54. Global Antivenom Sales Market Share in Value by Application (2021-2026) Table 55. Global Antivenom Price by Application (2021-2026) & (USD/Vial) Table 56. Global Antivenom Sales by Application (2027-2032) & (K Vials) Table 57. Global Antivenom Sales Market Share in Volume by Application (2027-2032) Table 58. Global Antivenom Sales by Application (2027-2032) & (US$ Million) Table 59. Global Antivenom Sales Market Share in Value by Application (2027-2032) Table 60. Global Antivenom Price by Application (2027-2032) & (USD/Vial) Table 61. North America Antivenom Sales by Application (2021-2026) & (K Vials) Table 62. North America Antivenom Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Antivenom Sales by Application (2021-2026) & (K Vials) Table 64. Europe Antivenom Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Antivenom Sales by Application (2021-2026) & (K Vials) Table 66. Asia-Pacific Antivenom Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Antivenom Sales by Application (2021-2026) & (K Vials) Table 68. Latin America Antivenom Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Antivenom Sales by Application (2021-2026) & (K Vials) Table 70. Middle East and Africa Antivenom Sales by Application (2021-2026) & (US$ Million) Table 71. CSL Company Information Table 72. CSL Business Overview Table 73. CSL Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 74. CSL Antivenom Product Portfolio Table 75. CSL Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 79. Merck Antivenom Product Portfolio Table 80. Merck Recent Development Table 81. BTG Company Information Table 82. BTG Business Overview Table 83. BTG Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 84. BTG Antivenom Product Portfolio Table 85. BTG Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 89. Pfizer Antivenom Product Portfolio Table 90. Pfizer Recent Development Table 91. Haffkine Bio-Pharmaceutical Company Information Table 92. Haffkine Bio-Pharmaceutical Business Overview Table 93. Haffkine Bio-Pharmaceutical Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 94. Haffkine Bio-Pharmaceutical Antivenom Product Portfolio Table 95. Haffkine Bio-Pharmaceutical Recent Development Table 96. Rare Disease Therapeutics Company Information Table 97. Rare Disease Therapeutics Business Overview Table 98. Rare Disease Therapeutics Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 99. Rare Disease Therapeutics Antivenom Product Portfolio Table 100. Rare Disease Therapeutics Recent Development Table 101. Flynn Pharma Company Information Table 102. Flynn Pharma Business Overview Table 103. Flynn Pharma Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 104. Flynn Pharma Antivenom Product Portfolio Table 105. Flynn Pharma Recent Development Table 106. Vins Bioproducts Company Information Table 107. Vins Bioproducts Business Overview Table 108. Vins Bioproducts Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 109. Vins Bioproducts Antivenom Product Portfolio Table 110. Vins Bioproducts Recent Development Table 111. Bharat Serums and Vaccines Company Information Table 112. Bharat Serums and Vaccines Business Overview Table 113. Bharat Serums and Vaccines Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 114. Bharat Serums and Vaccines Antivenom Product Portfolio Table 115. Bharat Serums and Vaccines Recent Development Table 116. Serum Biotech Company Information Table 117. Serum Biotech Business Overview Table 118. Serum Biotech Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 119. Serum Biotech Antivenom Product Portfolio Table 120. Serum Biotech Recent Development Table 121. MicroPharm Company Information Table 122. MicroPharm Business Overview Table 123. MicroPharm Antivenom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 124. MicroPharm Antivenom Product Portfolio Table 125. MicroPharm Recent Development Table 126. North America Antivenom Market Size Growth Rate (CAGR) by Country (K Vials): 2021 VS 2025 VS 2032 Table 127. North America Antivenom Sales by Country (2021-2026) & (K Vials) Table 128. North America Antivenom Sales Market Share by Country (2021-2026) Table 129. North America Antivenom Sales Forecast by Country (2027-2032) & (K Vials) Table 130. North America Antivenom Sales Market Share Forecast by Country (2027-2032) Table 131. North America Antivenom Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Antivenom Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Antivenom Market Share by Country (2021-2026) Table 134. North America Antivenom Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Antivenom Market Share Forecast by Country (2027-2032) Table 136. Europe Antivenom Market Size Growth Rate (CAGR) by Country (K Vials): 2021 VS 2025 VS 2032 Table 137. Europe Antivenom Sales by Country (2021-2026) & (K Vials) Table 138. Europe Antivenom Sales Market Share by Country (2021-2026) Table 139. Europe Antivenom Sales Forecast by Country (2027-2032) & (K Vials) Table 140. Europe Antivenom Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Antivenom Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Antivenom Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Antivenom Market Share by Country (2021-2026) Table 144. Europe Antivenom Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Antivenom Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Antivenom Market Size Growth Rate (CAGR) by Country (K Vials): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Antivenom Sales by Country (2021-2026) & (K Vials) Table 148. Asia-Pacific Antivenom Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Antivenom Sales Forecast by Country (2027-2032) & (K Vials) Table 150. Asia-Pacific Antivenom Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Antivenom Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Antivenom Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Antivenom Market Share by Country (2021-2026) Table 154. Asia-Pacific Antivenom Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Antivenom Market Share Forecast by Country (2027-2032) Table 156. Latin America Antivenom Market Size Growth Rate (CAGR) by Country (K Vials): 2021 VS 2025 VS 2032 Table 157. Latin America Antivenom Sales by Country (2021-2026) & (K Vials) Table 158. Latin America Antivenom Sales Market Share by Country (2021-2026) Table 159. Latin America Antivenom Sales Forecast by Country (2027-2032) & (K Vials) Table 160. Latin America Antivenom Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Antivenom Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Antivenom Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Antivenom Market Share by Country (2021-2026) Table 164. Latin America Antivenom Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Antivenom Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Antivenom Market Size Growth Rate (CAGR) by Country (K Vials): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Antivenom Sales by Country (2021-2026) & (K Vials) Table 168. Middle East and Africa Antivenom Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Antivenom Sales Forecast by Country (2027-2032) & (K Vials) Table 170. Middle East and Africa Antivenom Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Antivenom Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Antivenom Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Antivenom Market Share by Country (2021-2026) Table 174. Middle East and Africa Antivenom Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Antivenom Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Antivenom Distributors List Table 179. Antivenom Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Antivenom Image Figure 2. Global Antivenom Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antivenom Market Size (2021-2032) & (US$ Million) Figure 4. Global Antivenom Sales (2021-2032) & (K Vials) Figure 5. Polyvalent antivenom Image Figure 6. Global Polyvalent antivenom Sales YoY Growth (2021-2032) & (K Vials) Figure 7. Monovalent antivenom Image Figure 8. Global Monovalent antivenom Sales YoY Growth (2021-2032) & (K Vials) Figure 9. Global Antivenom Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Antivenom Market Share by Type 2025 VS 2032 Figure 11. North America Antivenom Sales Market Share in Volume by Type in 2025 Figure 12. North America Antivenom Sales Market Share in Value by Type in 2025 Figure 13. Europe Antivenom Sales Market Share in Volume by Type in 2025 Figure 14. Europe Antivenom Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Antivenom Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Antivenom Sales Market Share in Value by Type in 2025 Figure 17. Latin America Antivenom Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Antivenom Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Antivenom Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Antivenom Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Antivenom Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Non-profit Institutions Image Figure 24. Global Non-profit Institutions Sales YoY Growth (2021-2032) & (K Vials) Figure 25. Hospitals and Clinic Image Figure 26. Global Hospitals and Clinic Sales YoY Growth (2021-2032) & (K Vials) Figure 27. Global Antivenom Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Antivenom Market Share by Application 2025 VS 2032 Figure 29. North America Antivenom Sales Market Share in Volume by Application in 2025 Figure 30. North America Antivenom Sales Market Share in Value by Application in 2025 Figure 31. Europe Antivenom Sales Market Share in Volume by Application in 2025 Figure 32. Europe Antivenom Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Antivenom Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Antivenom Sales Market Share in Value by Application in 2025 Figure 35. Latin America Antivenom Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Antivenom Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Antivenom Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Antivenom Sales Market Share in Value by Application in 2025 Figure 39. North America Antivenom Sales by Country: 2021 VS 2025 VS 2032 (K Vials) Figure 40. North America Antivenom Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Antivenom Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Antivenom Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Antivenom Sales by Country: 2021 VS 2025 VS 2032 (K Vials) Figure 44. Europe Antivenom Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Antivenom Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Antivenom Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Antivenom Sales by Country: 2021 VS 2025 VS 2032 (K Vials) Figure 48. Asia-Pacific Antivenom Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Antivenom Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Antivenom Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Antivenom Sales by Country: 2021 VS 2025 VS 2032 (K Vials) Figure 52. Latin America Antivenom Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Antivenom Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Antivenom Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Antivenom Sales by Country: 2021 VS 2025 VS 2032 (K Vials) Figure 56. Middle East and Africa Antivenom Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Antivenom Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Antivenom Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Antivenom Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Antivenom Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Polyvalent antivenom
  • Monovalent antivenom
Applications
  • Non-profit Institutions
  • Hospitals and Clinic
Companies covered
  • CSL
  • Merck
  • BTG
  • Pfizer
  • Haffkine Bio-Pharmaceutical
  • Rare Disease Therapeutics
  • Flynn Pharma
  • Vins Bioproducts
  • Bharat Serums and Vaccines
  • Serum Biotech
  • MicroPharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antivenom Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antivenom Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antivenom Market by Type
  6. 1.3.1 Polyvalent antivenom
  7. 1.3.2 Monovalent antivenom
  8. 1.4 Global Antivenom Market Size by Type
  9. 1.4.1 Global Antivenom Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Antivenom Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Antivenom Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Antivenom Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Antivenom Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Antivenom Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Antivenom Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Antivenom Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antivenom Industry Trends
  2. 2.2 Antivenom Industry Drivers
  3. 2.3 Antivenom Industry Opportunities and Challenges
  4. 2.4 Antivenom Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antivenom Revenue (2021-2026)
  2. 3.2 Global Top Players by Antivenom Sales (2021-2026)
  3. 3.3 Global Top Players by Antivenom Price (2021-2026)
  4. 3.4 Global Antivenom Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antivenom Major Company Production Sites & Headquarters
  6. 3.6 Global Antivenom Company, Product Type & Application
  7. 3.7 Global Antivenom Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antivenom Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antivenom Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antivenom Tier 1, Tier 2, and Tier 3
4 Antivenom Regional Status and Outlook
  1. 4.1 Global Antivenom Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antivenom Historic Market Size by Region
  3. 4.2.1 Global Antivenom Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antivenom Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antivenom Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antivenom Forecasted Market Size by Region
  7. 4.3.1 Global Antivenom Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antivenom Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antivenom Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antivenom by Application
  1. 5.1 Antivenom Market by Application
  2. 5.1.1 Non-profit Institutions
  3. 5.1.2 Hospitals and Clinic
  4. 5.2 Global Antivenom Market Size by Application
  5. 5.2.1 Global Antivenom Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Antivenom Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Antivenom Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Antivenom Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Antivenom Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Antivenom Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Antivenom Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Antivenom Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CSL
  2. 6.1.1 CSL Company Information
  3. 6.1.2 CSL Business Overview
  4. 6.1.3 CSL Antivenom Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CSL Antivenom Product Portfolio
  6. 6.1.5 CSL Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Antivenom Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Antivenom Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 BTG
  14. 6.3.1 BTG Company Information
  15. 6.3.2 BTG Business Overview
  16. 6.3.3 BTG Antivenom Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 BTG Antivenom Product Portfolio
  18. 6.3.5 BTG Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Antivenom Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Antivenom Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Haffkine Bio-Pharmaceutical
  26. 6.5.1 Haffkine Bio-Pharmaceutical Company Information
  27. 6.5.2 Haffkine Bio-Pharmaceutical Business Overview
  28. 6.5.3 Haffkine Bio-Pharmaceutical Antivenom Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Haffkine Bio-Pharmaceutical Antivenom Product Portfolio
  30. 6.5.5 Haffkine Bio-Pharmaceutical Recent Developments
  31. 6.6 Rare Disease Therapeutics
  32. 6.6.1 Rare Disease Therapeutics Company Information
  33. 6.6.2 Rare Disease Therapeutics Business Overview
  34. 6.6.3 Rare Disease Therapeutics Antivenom Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Rare Disease Therapeutics Antivenom Product Portfolio
  36. 6.6.5 Rare Disease Therapeutics Recent Developments
  37. 6.7 Flynn Pharma
  38. 6.7.1 Flynn Pharma Company Information
  39. 6.7.2 Flynn Pharma Business Overview
  40. 6.7.3 Flynn Pharma Antivenom Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Flynn Pharma Antivenom Product Portfolio
  42. 6.7.5 Flynn Pharma Recent Developments
  43. 6.8 Vins Bioproducts
  44. 6.8.1 Vins Bioproducts Company Information
  45. 6.8.2 Vins Bioproducts Business Overview
  46. 6.8.3 Vins Bioproducts Antivenom Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Vins Bioproducts Antivenom Product Portfolio
  48. 6.8.5 Vins Bioproducts Recent Developments
  49. 6.9 Bharat Serums and Vaccines
  50. 6.9.1 Bharat Serums and Vaccines Company Information
  51. 6.9.2 Bharat Serums and Vaccines Business Overview
  52. 6.9.3 Bharat Serums and Vaccines Antivenom Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bharat Serums and Vaccines Antivenom Product Portfolio
  54. 6.9.5 Bharat Serums and Vaccines Recent Developments
  55. 6.10 Serum Biotech
  56. 6.10.1 Serum Biotech Company Information
  57. 6.10.2 Serum Biotech Business Overview
  58. 6.10.3 Serum Biotech Antivenom Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Serum Biotech Antivenom Product Portfolio
  60. 6.10.5 Serum Biotech Recent Developments
  61. 6.11 MicroPharm
  62. 6.11.1 MicroPharm Company Information
  63. 6.11.2 MicroPharm Business Overview
  64. 6.11.3 MicroPharm Antivenom Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 MicroPharm Antivenom Product Portfolio
  66. 6.11.5 MicroPharm Recent Developments
7 North America by Country
  1. 7.1 North America Antivenom Sales by Country
  2. 7.1.1 North America Antivenom Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antivenom Sales by Country (2021-2026)
  4. 7.1.3 North America Antivenom Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antivenom Market Size by Country
  6. 7.2.1 North America Antivenom Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antivenom Market Size by Country (2021-2026)
  8. 7.2.3 North America Antivenom Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antivenom Sales by Country
  2. 8.1.1 Europe Antivenom Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antivenom Sales by Country (2021-2026)
  4. 8.1.3 Europe Antivenom Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antivenom Market Size by Country
  6. 8.2.1 Europe Antivenom Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antivenom Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antivenom Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antivenom Sales by Country
  2. 9.1.1 Asia-Pacific Antivenom Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antivenom Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antivenom Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antivenom Market Size by Country
  6. 9.2.1 Asia-Pacific Antivenom Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antivenom Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antivenom Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antivenom Sales by Country
  2. 10.1.1 South America Antivenom Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antivenom Sales by Country (2021-2026)
  4. 10.1.3 South America Antivenom Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antivenom Market Size by Country
  6. 10.2.1 South America Antivenom Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antivenom Market Size by Country (2021-2026)
  8. 10.2.3 South America Antivenom Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antivenom Sales by Country
  2. 11.1.1 Middle East and Africa Antivenom Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antivenom Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antivenom Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antivenom Market Size by Country
  6. 11.2.1 Middle East and Africa Antivenom Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antivenom Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antivenom Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antivenom Value Chain Analysis
  2. 12.1.1 Antivenom Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antivenom Production Mode & Process
  7. 12.2 Antivenom Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antivenom Distributors
  10. 12.2.3 Antivenom Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst